Uterine Leiomyoma Clinical Trial
Official title:
Postpartum Uterine Regression
Uterine leiomyomas are the leading cause of hysterectomy in the United States, accounting for over 200,000 procedures each year. Most epidemiologic studies of uterine leiomyoma show that parity has a protective association with leiomyoma, but the mechanism is not known. Both epidemiologic data and data from an animal model indicate that the protective association is not an artifact resulting from reduced fertility among women with fibroids. We hypothesize that the process of uterine regression following delivery results in loss of small fibroids due to selective apoptosis of transformed cells and the extensive remodeling of the entire uterus.
Background: Uterine leiomyomas are the leading cause of hysterectomy in the United States,
accounting for over 200,000 procedures each year. Most epidemiologic studies of uterine
leiomyoma show that parity has a protective association with leiomyoma, but the mechanism is
not known. Both epidemiologic data and data from an animal model indicate that the protective
association is not an artifact resulting from reduced fertility among women with fibroids. We
hypothesize that the process of uterine regression following delivery results in loss of
small fibroids due to selective apoptosis of transformed cells and the extensive remodeling
of the entire uterus.
Study Objectives: Monitor fibroids during pregnancy and after postpartum uterine regression
to assess any loss of fibroids and change in size of fibroids.
Methods: Add a postpartum ultrasound examination to an existing epidemiologic study of
pregnant women. The parent study documents fibroid number, size, and location with a 7 week
ultrasound examination. With the additional postpartum ultrasound proposed here, data on
fibroid number, size, and location through pregnancy and postpartum uterine regression will
be collected on approximately 400 women. A subsample of 30 women will also have an MRI after
their postpartum ultrasound in order to evaluate the sensitivity of ultrasound imaging.
Significance: This study will provide the first data on fibroid change with
parturition/postpartum uterine regression for a large sample of women. If small fibroids
disappear during this time, it will document a process that results in "natural regression"
of these tumors in premenopausal women. Insights from the biology of this process may be
useful in developing treatment that could be used by nonpregnant women with fibroids to
induce tumor regression.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Not yet recruiting |
NCT03219385 -
Directed Ablation of Uterine Fibroids Using a Noninvasive Approach
|
N/A | |
Completed |
NCT01338831 -
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
|
Phase 1 | |
Completed |
NCT01468402 -
Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma
|
N/A | |
Completed |
NCT03847077 -
Trial of a Patient Education Tool For Leiomyoma
|
N/A | |
Completed |
NCT00365989 -
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
|
Phase 3 | |
Completed |
NCT03751124 -
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
Phase 3 | |
Recruiting |
NCT02495311 -
The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
|
||
Completed |
NCT00332033 -
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
|
Phase 2 | |
Completed |
NCT04874246 -
Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy
|
N/A | |
Not yet recruiting |
NCT04282863 -
Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM)
|
N/A | |
Recruiting |
NCT06115408 -
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
|
Phase 2/Phase 3 | |
Completed |
NCT02059954 -
Vaginal vs. Laparoscopic Hysterectomy
|
N/A | |
Completed |
NCT02049242 -
Uterine Tourniquet at Open Myomectomy
|
N/A | |
Terminated |
NCT01738724 -
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
|
Phase 4 | |
Terminated |
NCT01280045 -
Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy
|
N/A | |
Withdrawn |
NCT02736435 -
Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
|
Phase 3 | |
Completed |
NCT04819633 -
Evaluating Serum Sestrin in Leiomyoma Patients
|
||
Completed |
NCT01715597 -
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
|
Phase 3 | |
Completed |
NCT03328260 -
High Intensity Focused Ultrasound in Uterine Myoma
|
N/A |